Phase 3 Data Highlight Benefits Of Using VELCADE® Within Frontline Treatment Of Mantle Cell Lymphoma, With Results Showing Significantly Longer Progression-Free Survival Compared To Standard Of Care
- EMEA Innovative Medicine
- Phase 3 Data on Use of VELCADE® Treatment Of Mantle Cell Lymphoma
Phase 3 Data on Use of VELCADE® Treatment Of Mantle Cell Lymphoma
- X (Twitter)
Copy link